BioVectra Inc
$21,114,000.00 CAD
- Program
- SIF Stream2- Growth
- Recipient country
- Canada
- Fiscal year
- 2017-2018
- Agreement period
- September 14, 2017 – March 31, 2021
- Reference
- ic:033-2018-2019-Q4-811152
Published purpose
The project will increase BioVectra's contribution to medicine production capacity and support the research and development of advanced pharmaceutical products not currently manufactured in Canada.
In plain English AI-generated
This federal contribution supports BioVectra Inc. to expand medicine production capacity and advance research and development of new pharmaceutical products not currently made in Canada.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.